Skip to content
PubMed This is a summary of 37 peer-reviewed journal articles Updated
Dermatology

Starting Your Journey with EPPK

At a Glance

Epidermolytic palmoplantar keratoderma (EPPK) is a rare genetic skin disorder causing severe thickening of the palms and soles. Caused by KRT9 or KRT1 gene mutations, it cannot be cured but is managed with skin-softening treatments like keratolytics and oral retinoids to prevent cracking.

Receiving a diagnosis of Epidermolytic palmoplantar keratoderma (EPPK)—also known as Vörner type—can feel overwhelming. Because it is a rare condition, you may have spent months or even years searching for an answer. This page is designed to help you ground yourself in the facts and find a path forward.

Understanding Your Diagnosis

EPPK is a rare, hereditary skin disorder characterized by a significant thickening of the skin on the palms of the hands and the soles of the feet [1][2]. The term epidermolytic refers to a specific pattern seen under a microscope where the skin cells appear to be breaking down or “dissolving” in the upper layers of the epidermis due to structural weakness [2][3].

The condition is primarily caused by mutations in the KRT9 or KRT1 genes [2][4]. These genes provide instructions for making keratin, a protein that forms the structural framework of your skin. When these proteins are faulty, the skin becomes fragile and overcompensates by thickening (hyperkeratosis) to protect itself [5][2].

Stabilizing Facts

When first diagnosed, it is helpful to focus on these core truths:

  • It is manageable, not your fault: EPPK is a genetic condition you were born with. While there is currently no cure, there are many effective ways to manage symptoms and maintain a high quality of life [6][7].
  • Inheritance is predictable: EPPK is usually autosomal dominant. This means if one parent has the gene, there is a 50% chance of passing it to each child [2][5]. In very rare cases, it can be autosomal recessive, meaning a child only develops it if they inherit a mutated gene from both parents who are carriers [2].
  • Targeted Care Exists: While general dermatologists treat common issues like acne, “genodermatosis” specialists focus on rare genetic skin conditions and can offer the most current management strategies [8].

The Emotional Impact of a Rare Diagnosis

It is normal to feel a range of emotions after an EPPK diagnosis, including:

  • Relief: Finally having a name for the symptoms you or your child have been experiencing [9].
  • Isolation: Feeling alone because few people (including some doctors) have heard of the condition [9].
  • Anxiety: Worrying about future physical limitations, pain, or the “diagnostic journey” of navigating the healthcare system [10][9].

Research shows a strong link between rare skin conditions and mental health. Integrating psychological support into your care plan is often just as important as topical creams [10].

What to Expect Long-Term

EPPK typically appears in early infancy or childhood [2]. The skin on the palms and soles becomes thick, yellowed, and may develop a “halo” of redness around the edges.

  • Mobility: Thickened skin on the feet can sometimes cause pain or cracking (fissures), which may affect walking [6][11].
  • Expertise: You may find yourself becoming the “expert” on your own condition. This is a common experience for those with rare diseases and highlights the importance of a supportive, multidisciplinary medical team [9][12].
  • Treatment Goals: Therapy focuses on softening the skin and reducing thickness using keratolytics (like salicylic acid or urea) and, in some cases, oral medications called retinoids [6][13][14].
Key Term Plain Language Definition
Keratoderma Marked thickening of the skin’s outer layer.
Palmoplantar Relating to the palms of the hands and soles of the feet.
Mutation A change or “typo” in a gene’s DNA sequence.
Hyperkeratosis The medical term for the thickening of the skin’s keratin layer.

Common questions in this guide

What causes Epidermolytic palmoplantar keratoderma (EPPK)?
EPPK is caused by genetic mutations, most commonly in the KRT9 or KRT1 genes. These genes provide instructions for making keratin, and when they are faulty, the skin becomes fragile and thickens to protect itself.
How is EPPK inherited?
The condition is usually inherited in an autosomal dominant pattern. This means that if one parent has the mutated gene, there is a 50 percent chance of passing it to each of their children.
What are the best treatments for thick skin in EPPK?
Treatment focuses on softening the skin and reducing thickness. Dermatologists often recommend keratolytics containing salicylic acid or urea, and in more severe cases, oral medications called retinoids may be prescribed.
What kind of doctor should I see for EPPK?
While general dermatologists can provide care, it is highly recommended to see a specialist in genodermatoses. These doctors specialize in rare genetic skin conditions and can offer the most current, targeted management strategies.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Has genetic testing been performed to confirm a KRT9 or KRT1 mutation?
  2. 2.Is this case 'non-transgradient' (only palms/soles) or should we watch for extension to the back of the hands and feet?
  3. 3.What is the best daily routine to manage thickening and prevent painful cracking (fissures)?
  4. 4.Can you refer us to a dermatologist who specializes in genodermatoses (genetic skin conditions)?
  5. 5.Does my child have any other risks, such as hearing issues or heart concerns, that are sometimes linked to other types of keratoderma?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Exome sequencing identifies a KRT9 pathogenic variant in a Chinese pedigree with epidermolytic palmoplantar keratoderma.

    Li C, Chen P, Sun S, et al.

    Molecular genetics & genomic medicine 2019; (7(7)):e00703 doi:10.1002/mgg3.703.

    PMID: 31074163
  2. 2

    Keratin 9 L164P mutation in a Chinese pedigree with epidermolytic palmoplantar keratoderma, cytokeratin analysis, and literature review.

    Liu X, Qiu C, He R, et al.

    Molecular genetics & genomic medicine 2019; (7(11)):e977 doi:10.1002/mgg3.977.

    PMID: 31525823
  3. 3

    A p.478I>T KRT1 mutation in a case of annular epidermolytic ichthyosis.

    Zaki TD, Yoo KY, Kassardjian M, Choate KA

    Pediatric dermatology 2018; (35(6)):e414-e415 doi:10.1111/pde.13643.

    PMID: 30152556
  4. 4

    A novel mutation of KRT9 gene in a Chinese Han pedigree with epidermolytic palmoplantar keratoderma.

    Chen N, Sun J, Song Y, et al.

    Journal of cosmetic dermatology 2017; (16(3)):402-406 doi:10.1111/jocd.12263.

    PMID: 27726289
  5. 5

    Genetic lessons learned from pathogenic variants in KRT1.

    Betz RC

    Journal of the European Academy of Dermatology and Venereology : JEADV 2022; (36(10)):1683-1684 doi:10.1111/jdv.18510.

    PMID: 36106438
  6. 6

    Treatment of hereditary palmoplantar keratoderma: a review by analysis of the literature.

    Bodemer C, Steijlen P, Mazereeuw-Hautier J, O'Toole EA

    The British journal of dermatology 2021; (184(3)):393-400 doi:10.1111/bjd.19144.

    PMID: 32307694
  7. 7

    Novel compound heterozygous mutation in CTSC gene with response to ustekinumab.

    Latour-Álvarez I, Ortega-Ramírez J, Alonso-Serrano E, Torrelo A

    Journal of the European Academy of Dermatology and Venereology : JEADV 2023; (37(6)):e798-e800 doi:10.1111/jdv.18938.

    PMID: 36740595
  8. 8

    Genetic skin disorders: The value of a multidisciplinary clinic.

    Parker JC, Rangu S, Grand KL, et al.

    American journal of medical genetics. Part A 2021; (185(4)):1159-1167 doi:10.1002/ajmg.a.62095.

    PMID: 33502802
  9. 9

    The lived experience of having a rare medical disorder: Hermansky-Pudlak syndrome.

    Christensen S, Wagner L, Coleman MM, Appell D

    Chronic illness 2017; (13(1)):62-72 doi:10.1177/1742395316655854.

    PMID: 27358286
  10. 10

    The Depressiveness, Quality of Life and NEO-FFI Scale in Patients with Selected Genodermatoses.

    Wawrzycki B, Fryze M, Mlak R, et al.

    Journal of clinical medicine 2024; (13(6)) doi:10.3390/jcm13061624.

    PMID: 38541849
  11. 11

    Striate palmoplantar keratoderma resulting from a missense mutation in DSG1.

    Vodo D, O'Toole EA, Malchin N, et al.

    The British journal of dermatology 2018; (179(3)):755-757 doi:10.1111/bjd.16320.

    PMID: 29315490
  12. 12

    Transgradient Variant of Mal De Meleda Presenting As Palmoplantar Keratoderma: A Case Report.

    Khan A, Singh A, Madke B, et al.

    Cureus 2024; (16(5)):e60717 doi:10.7759/cureus.60717.

    PMID: 38903266
  13. 13

    Palmoplantar Keratoderma in Costello Syndrome Responsive to Acitretin.

    Marukian NV, Levinsohn JL, Craiglow BG, et al.

    Pediatric dermatology 2017; (34(2)):160-162 doi:10.1111/pde.13057.

    PMID: 28008647
  14. 14

    A Rare Case on Capecitabine Induced Acquired Palmoplantar Keratoderma.

    Tsaqilah L, Mudia KAM, Usman HA, et al.

    Clinical, cosmetic and investigational dermatology 2023; (16()):3713-3718 doi:10.2147/CCID.S442194.

    PMID: 38152152

This page provides educational information about Epidermolytic palmoplantar keratoderma (EPPK). It does not replace professional medical advice, and you should always consult a dermatologist or genodermatosis specialist for a personalized care plan.

Get notified when new evidence is published on Epidermolytic palmoplantar keratoderma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.